1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/33756
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-09-05T12:28:29Z-
dc.date.available2023-09-05T12:28:29Z-
dc.date.issued2017-06-26-
dc.identifier.citationFerhanoğlu, B. vd. (2017). ''Nivolumab for relapsed or refractory hodgkin lymphoma: Experience in Turkey''. Haematologica, 102(Supplement 2), 84-85.en_US
dc.identifier.issn0390-6078-
dc.identifier.urihttp://hdl.handle.net/11452/33756-
dc.descriptionBu çalışma, 22-25 Haziran 2017 tarihlerinde Madrid[İspanya]’da düzenlenen 22. Congress of the European-Hematology-Association Kongresi‘nde bildiri olarak sunulmuştur.tr_TR
dc.descriptionÇalışmada 29 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır.tr_TR
dc.description.sponsorshipEuropean Hematol Assocationen_US
dc.language.isoenen_US
dc.publisherFerrata Storti Foundationen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHematologyen_US
dc.titleNivolumab for relapsed or refractory hodgkin lymphoma: Experience in Turkeyen_US
dc.typeMeeting Abstracten_US
dc.identifier.wos000404127001176tr_TR
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Dahiliye Anabilim Dalı.tr_TR
dc.identifier.startpage84tr_TR
dc.identifier.endpage85tr_TR
dc.identifier.volume102tr_TR
dc.identifier.issueSupplement 2en_US
dc.relation.journalHaematologicaen_US
dc.contributor.buuauthorÖzkocaman, Vildan-
dc.contributor.researcheridAAH-1854-2021tr_TR
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.subject.wosHematologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.wos.quartileQ1en_US
Appears in Collections:Web of Science

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.